Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03367936 · ClinicalTrials.gov registry record · NA
Promoting Lifestyle Change Via Tailored mHealth Feedback to Improve Health
A NA study of Overweight and Obesity, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 502
- Enrollment target
- 1
- Study location
NCT03367936: Completed NA study of Overweight and Obesity, sponsored by University of Pittsburgh.
NCT03367936 is a NA study of Overweight and Obesity that has completed, run by University of Pittsburgh. The registered enrollment target is 502 participants, above the 224-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (124% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03367936, a NA study of Overweight and Obesity, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 502 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall purpose of this randomized clinical trial is to examine the effect and efficacy of the individualized, real-time, smartphone-based feedback of diet and physical activity self-monitoring on subsequent weight-control behaviors, weight loss outcomes and sustainability of patient engagement. Participants will be randomized to one of 2 groups: (1) Self-Monitoring -similar to what many people do on their own, subjects will self-monitor diet, physical activity using Fitbit and weight using a Bluetooth-enabled scale, and (2) Self-Monitoring +Feedback-participants will self-monitor as described for the Self-Monitoring group but also will receive tailored Feedback messages. The Self-Monitoring +Feedback participants will receive up to 4 daily discrete pop-up Feedback messages on the participant's smartphone delivered at random times during waking hours and tailored to content of recorded entries in the subjects' smartphone-based diaries and a weekly summary Feedback message about the participant's weight.
Primary Outcome
Changes in weight: measured as percent change in weight from baseline to 6 and 12 months
Conditions Studied
Interventions
- BEHAVIORAL Self-monitoring
- BEHAVIORAL Feedback
- BEHAVIORAL One-on-one Session
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 502 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
What the finished NCT03367936 record still lists
NCT03367936 is an interventional study that assigns participants to a tested intervention. The registered 502 participants enrollment target is mid-sized for trials with a published cap, above the 224-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (124% higher).
The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 3 interventions - of which Self-monitoring is the first listed.
NCT03367936 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03367936 about?
NCT03367936 is a clinical study titled "Promoting Lifestyle Change Via Tailored mHealth Feedback to Improve Health". The overall purpose of this randomized clinical trial is to examine the effect and efficacy of the individualized, real-time, smartphone-based feedback of diet and physical activity self-monitoring on subsequent weight-control behaviors, weight loss outcomes and sustainability of patient engagement....
What is the current status of trial NCT03367936?
This trial is currently completed. It is a NA study. The enrollment target is 502 participants. The study started on 2018-08-01. Estimated completion is 2021-03-31.
What conditions does trial NCT03367936 study?
This clinical trial studies the following conditions: Overweight and Obesity.
What interventions are being tested in trial NCT03367936?
The interventions under investigation include: Self-monitoring (BEHAVIORAL), Feedback (BEHAVIORAL), One-on-one Session (BEHAVIORAL).
Who is sponsoring clinical trial NCT03367936?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03367936 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03367936's enrollment target sits among peer trials
502 14th of 115 higher than 102 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05646381 · 502 participants · Phase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
- NCT05897632 · 502 participants · NA
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
- NCT05143931 · 503 participants · NA
Avoid and Resist Strategies for Weight Management
- NCT04442022 · 501 participants · Phase 2
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI